Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 304

    1.

    A prognostic model for predicting 10-year survival in patients with primary melanoma. The Pigmented Lesion Group.

    Schuchter L, Schultz DJ, Synnestvedt M, Trock BJ, Guerry D, Elder DE, Elenitsas R, Clark WH, Halpern AC.

    Ann Intern Med. 1996 Sep 1;125(5):369-75.PMID: 8702087 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Predicting ten-year survival of patients with primary cutaneous melanoma: corroboration of a prognostic model.

    Sahin S, Rao B, Kopf AW, Lee E, Rigel DS, Nossa R, Rahman IJ, Wortzel H, Marghoob AA, Bart RS.

    Cancer. 1997 Oct 15;80(8):1426-31.PMID: 9338466 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Prognostic models in melanoma.

    Halpern AC, Schuchter LM.

    Semin Oncol. 1997 Feb;24(1 Suppl 4):S2-7.PMID: 9122730 [PubMed - indexed for MEDLINE]Related articles

    4.

    Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.

    Thörn M, Pontén F, Bergström R, Sparén P, Adami HO.

    J Natl Cancer Inst. 1994 May 18;86(10):761-9.PMID: 8169974 [PubMed - indexed for MEDLINE]Related articles

    5.

    Predicting five-year outcome for patients with cutaneous melanoma in a population-based study.

    Barnhill RL, Fine JA, Roush GC, Berwick M.

    Cancer. 1996 Aug 1;78(3):427-32. Erratum in: Cancer 1997 Jan 15;79(2):423. PMID: 8697387 [PubMed - indexed for MEDLINE]Related articles

    6.

    Desmoplasia and neurotropism. Prognostic variables in patients with stage I melanoma.

    Baer SC, Schultz D, Synnestvedt M, Elder DE.

    Cancer. 1995 Dec 1;76(11):2242-7.PMID: 8635027 [PubMed - indexed for MEDLINE]Related articles

    8.

    Age as a prognostic factor in the malignant melanoma population.

    Austin PF, Cruse CW, Lyman G, Schroer K, Glass F, Reintgen DS.

    Ann Surg Oncol. 1994 Nov;1(6):487-94.PMID: 7850555 [PubMed - indexed for MEDLINE]Related articles

    9.

    Gene expression profiling of primary cutaneous melanoma and clinical outcome.

    Winnepenninckx V, Lazar V, Michiels S, Dessen P, Stas M, Alonso SR, Avril MF, Ortiz Romero PL, Robert T, Balacescu O, Eggermont AM, Lenoir G, Sarasin A, Tursz T, van den Oord JJ, Spatz A; Melanoma Group of the European Organization for Research and Treatment of Cancer.

    J Natl Cancer Inst. 2006 Apr 5;98(7):472-82.PMID: 16595783 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Individualized prognosis for melanoma patients.

    Cochran AJ, Elashoff D, Morton DL, Elashoff R.

    Hum Pathol. 2000 Mar;31(3):327-31.PMID: 10746675 [PubMed - indexed for MEDLINE]Related articles

    11.

    The sentinel lymph node status is an important factor for predicting clinical outcome in patients with Stage I or II cutaneous melanoma.

    Statius Muller MG, van Leeuwen PA, de Lange-De Klerk ES, van Diest PJ, Pijpers R, Ferwerda CC, Vuylsteke RJ, Meijer S.

    Cancer. 2001 Jun 15;91(12):2401-8.PMID: 11413531 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Predicting survival and recurrence in localized melanoma: a multivariate approach.

    Soong SJ, Shaw HM, Balch CM, McCarthy WH, Urist MM, Lee JY.

    World J Surg. 1992 Mar-Apr;16(2):191-5.PMID: 1561798 [PubMed - indexed for MEDLINE]Related articles

    13.

    Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients.

    Garbe C, Büttner P, Bertz J, Burg G, d'Hoedt B, Drepper H, Guggenmoos-Holzmann I, Lechner W, Lippold A, Orfanos CE, et al.

    Cancer. 1995 May 15;75(10):2484-91.PMID: 7736392 [PubMed - indexed for MEDLINE]Related articles

    14.

    The long-term clinical course of patients with cutaneous melanoma.

    Gamel JW, George SL, Edwards MJ, Seigler HF.

    Cancer. 2002 Sep 15;95(6):1286-93.PMID: 12216097 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Can elective lymph node dissection decrease the frequency and mortality rate of late melanoma recurrences?

    Shen P, Guenther JM, Wanek LA, Morton DL.

    Ann Surg Oncol. 2000 Mar;7(2):114-9.PMID: 10761789 [PubMed - indexed for MEDLINE]Related articles

    16.

    Validation of a melanoma prognostic model.

    Margolis DJ, Halpern AC, Rebbeck T, Schuchter L, Barnhill RL, Fine J, Berwick M.

    Arch Dermatol. 1998 Dec;134(12):1597-601.PMID: 9875200 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Thin melanomas: predictive lethal characteristics from a 30-year clinical experience.

    Kalady MF, White RR, Johnson JL, Tyler DS, Seigler HF.

    Ann Surg. 2003 Oct;238(4):528-35; discussion 535-7.PMID: 14530724 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model.

    Tuthill RJ, Unger JM, Liu PY, Flaherty LE, Sondak VK; Southwest Oncology Group.

    Am J Clin Pathol. 2002 Oct;118(4):504-11.PMID: 12375635 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Comparison of two prognostic models predicting survival in patients with malignant melanoma.

    Pritchard ML, Woosley JT.

    Hum Pathol. 1995 Sep;26(9):1028-31.PMID: 7672785 [PubMed - indexed for MEDLINE]Related articles

    20.

    A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma.

    Balch CM, Soong SJ, Murad TM, Ingalls AL, Maddox WA.

    Surgery. 1979 Aug;86(2):343-51.PMID: 462379 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data